PND31 ECONOMIC EVALUATION OF ABOBOTULINUM TOXIN A VS ONABOTULINUM TOXIN A IN REAL-LIFE CLINICAL MANAGEMENT OF POST-STROKE UPPER LIMB SPASTICITY
May 1, 2019, 00:00 AM
10.1016/j.jval.2019.04.1304
https://www.valueinhealthjournal.com/article/S1098-3015(19)31496-2/fulltext
Section Title :
Section Order :
10805
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)31496-2&doi=10.1016/j.jval.2019.04.1304